Altered expression of NUCB2/nesfatin-1 in plasma, hypothalamus and brainstem is associated with HPA axis activity and TPH expression in chronically stressed rats.
Aug 2026· Pharmacology, Biochemistry and Behavior· Vol 268, pp.
174258
· 0 citations· 27 references
Medicine
TL;DR
Preliminary correlational evidence for coordinated NUCB2/nesfatin-1 changes across peripheral and central systems under stress-induced depression is provided, suggesting NUCB2/nesfatin-1 may link neuroendocrine activity and serotonergic plasticity with the brainstem as a core site.
Abstract
Background
The anorectic peptide nesfatin-1 has been identified as a potential mood regulator. Abnormal nesfatin-1 expression has been observed in both depression animal models and clinical cohorts, but its exact role in depression pathogenesis remains unclear.
Aim
This study aimed to detect peripheral and central nesfatin-1 alterations in rats with chronic unpredictable mild stress (CUMS)-induced depressive-like behaviors, and explore their correlations with hypothalamic-pituitary-adrenal (HPA) axis activity and brainstem monoamine synthesis.
Methods
Rats were subjected to 5-week CUMS. Enzyme-linked immunosorbent assay (ELISA) quantified plasma mature nesfatin-1 peptide, and Western blot (WB) detected full-length nucleobindin 2 (NUCB2)/nesfatin-1 in the hypothalamus and brainstem. Spearman's rank correlation was performed solely within the CUMS group (n = 6); these exploratory correlational findings require cautious interpretation due to small sample size.
Results
CUMS significantly increased plasma nesfatin-1 as well as hypothalamic and brainstem NUCB2/nesfatin-1. In CUMS rats, plasma nesfatin-1 was positively correlated with corticosterone and forced swim test (FST) immobility time, and negatively correlated with sucrose preference index(SPT) and weight gain. Brainstem NUCB2/nesfatin-1 showed a positive correlation with tryptophan hydroxylase (TPH), while no significant correlation was found between hypothalamic NUCB2/nesfatin-1 and all measured parameters.
Conclusion
Chronic stress-induced nesfatin-1 elevation accompanies peripheral HPA hyperactivation and aggravated depressive-like behaviors. Brainstem NUCB2/nesfatin-1 positively correlates with TPH, suggesting NUCB2/nesfatin-1 may link neuroendocrine activity and serotonergic plasticity with the brainstem as a core site. This study provides preliminary correlational evidence for coordinated NUCB2/nesfatin-1 changes across peripheral and central systems under stress-induced depression.
Mechanistically, CPE activated the BDNF/Nrf2 axis, increased GPX4 activity, suppressed acyl-CoA synthetase long chain family member 4 expression, and reduced iron accumulation, and all protective effects of CPE overexpression were reversed by ML385.
Wenjie Li, Fanying Meng, Ji-Zhen Li et al.· Neurochemical Research· 0 citations
MC1R-related signaling in the PFC is highlighted as an important contributor to inflammation-associated depression and NDP-MSH alleviates inflammation-associated depressive-like behaviors in association with melanocortin signaling involving MC1R and downstream cAMP/PKA activation.
Shang-Lan Qu, Xin Peng, Jie-Yu Ji et al.· Frontiers in Pharmacology· 0 citations
Findings provide new immunohistochemical evidence linking glutamatergic transmission to stress-induced Nesfatin-1 activation, with potential implications for the neurobiological interaction between inflammation, energy homeostasis, and stress-related processes.
G. Ekizceli, Kiymet Zulal Uygul, İ. M. Kafa et al.· Tissue & Cell· 0 citations
Investigation of how a single intranasal administration of UCN2 or UCN3 modulates bacterial composition and inflammatory activity in the spleen/isolated splenocytes and alters the expression of neuroinflammatory and neurogenic markers in the dorsal and ventral hippocampus in male rats exposed to single prolonged stress...
Lila Dziewiczova, A. Tillinger, L. Horvathova et al.· Neuropeptides· 0 citations
ALDOC may contribute to PPD pathogenesis by promoting Th1 polarization and inflammatory activation and may suggest coordinated central neuroinflammation and peripheral immune imbalance.
Zhi-Xin Du, Pengbei Fan, Yazhe Fan et al.· Psychiatry Research· 0 citations
Stigmasterol exhibits significant therapeutic effects against CPP by concurrently targeting the IGF-1/PI3K/Akt/mTOR and Kisspeptin/GnRH signaling pathways.
Lin Dong, Yan Xing, Xiaoning Li et al.· Biochimica et Biophysica Act...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.